Danish pharma major Novo Nordisk has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for once-weekly CagriSema (cagrilintide and semaglutide) injection, to be used ...
AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon ​to announce agreements with the U. government to lower certain prescription drug prices, ‌according ...
The populations of wealthy western nations are getting older and sicker, while emerging countries are demanding better ...